Study of the effects of casein-derived peptides on cognitive function -A randomized, double-blind, placebo-controlled, parallel-group study-

Study of the effects of casein-derived peptides on cognitive function -A randomized, double-blind, placebo-controlled, parallel-group study- - Effects of casein-derived peptides on cognitive function

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032833

Enrollment

300

Registered

2018-06-04

Start date

2018-06-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Ingestion of test food for 24 weeks Ingestion of placebo for 24 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Subjects who are age of 40 years or older. 2) Subjects who shows 21 or more scores in HDS-R.

Exclusion criteria

Exclusion criteria: 1) Subjects who have been diagnosed with dementia or suspected of dementia. 2) Subjects who have been suspected of mental disorders such as schizophrenia and depression. 3) Subjects who have serious disease or medical history in brain, liver, kidney, heart, lung, gastrointestinal tract, blood, or endocrine metabolism, etc. 4) Subjects who are pregnant or under lactation, or who is expected to be pregnant during the study. 5) Subjects who have a medical history of serious allergy to medicine and food. 6) Subjects who are judged unsuitable for participating in this study by doctors.

Design outcomes

Primary

Measure	Time frame
Neuropsychological tests (ADAS-Jcog)	—

Secondary

Measure	Time frame
Neuropsychological tests (HDS-R, MoCA-J) QOL	—

Countries

Japan

Contacts

Public ContactAkira Shimamura

Matsumoto Health Lab None

shimamura@m-health-lab.jp0263-39-1139

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026